Year Report for: 1935

Bacq_1935_Arch.Int.Physiol_42_24	Recherches sur la physiologie et la pharmacologie du systeme nerveux autonome
Dale_1935_Proc.R.Soc.Med_28_319	Pharmacology and Nerve-endings (Walter Ernest Dixon Memorial Lecture): (Section of Therapeutics and Pharmacology)
Dale_1935_Science_82_99	The new ergot alkaloid
Dudley_1935_Br.Med.J_1_520	The substance for the traditional clinical effect of ergot
Dudley_1935_Science_81_559	The new active principle of ergot
Julian_1935_J.Am.Chem.Soc_57_755	Studies in indole series. V. Complete synthesis of physostigmine (eserine)
Keith_1935_Arch.Neurol.Psychiatry_34_1022	Experimental convulsions induced by administration of thujone
Kirsh_1935_Int.J.Plant.Sci_97_321	Lipase Production by Penicillium Oxalicum and Aspergillus flavus
Lange_1935_Chem.Ztg_59_393	Fortschritte auf dem Gebiete der Darstellung und Verwendung von Fluorverbiridungen
Rossi_1935_Arch.Ophthalmol_42_341	Azzione sull'occhio di un nuovo farmaco sintetico exerino-simile: la prostigmina (Ricerche sperimetali e cliniche)
Stedman_1935_Biochem.J_29_2107	The relative cholinesterase activities of serum and corpuscles from the blood of certain species
Walker_1935_Proc.Roy.Soc.Med_28_759	Case showing effect of prostigmin on myasthenia gravis

Send your questions or comments to :Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.

For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page